CPE News (12/8/2020) – Southern Harvest Health Corp. has filed a preliminary prospectus in connection with a proposed initial public offering of up to 3,000,000 common shares at $0.50 per share for gross proceeds of up to $1,500,000.
Southern Harvest Health intends to apply to the Canadian Securities Exchange (CSE) for conditional approval to list its shares. The shares are anticipated to trade under the symbol “SHHC”.
On August 20, 2020, Southern Harvest Health Corp., an Ontario corporation, acquired all the issued and outstanding shares of STHC – SOUTHERN HARVEST CORP, UNIPESSOAL LDA (STHC), a private limited company incorporated in Portugal.
Upon closing of the offering, Southern Harvest Health will have 27,030,100 common shares outstanding. Clifford Starke, CEO of Panama based Franchise Cannabis Corp., is the single largest shareholder.
Lisbon, Portugal based Southern Harvest is a European focused cannabis cultivation company focused on high quality, medical grade flower and extracts production. The company’s main base of operations is located in Santarem District, Portugal.
photo credit: Southern Harvest
News Release
SOUTHERN HARVEST ANNOUNCES INITIAL PUBLIC OFFERING
Vancouver, British Columbia – December 8, 2020 – Southern Harvest Health Corp. (“Southern Harvest” or the “Company”) announced today that it has filed a preliminary prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in each of the Canadian provinces of Ontario, British Columbia, Alberta and Saskatchewan in connection with a proposed initial public offering (the “Offering”) of its common shares for total gross proceeds of up to $1,500,000. Industrial Alliance Securities Inc. is acting as agent in connection with the Offering.
A copy of the Preliminary Prospectus, which contains important information relating to the Offering, will be available on SEDAR (www.sedar.com). The Preliminary Prospectus is subject to completion or amendment. There will not be any sale or any acceptance of an offer to buy the common shares until a receipt for the final prospectus has been issued. Completion of the Offering is subject to and conditional upon the receipt of all necessary approvals, including regulatory approvals.
No securities regulatory authority has either approved or disapproved the contents of this news release. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933 (the “U.S. Securities Act”), as amended, or any state securities laws. Accordingly, the securities may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or except pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities offered hereby within the United States.
About Southern Harvest
Southern Harvest is a Canadian medical cannabis company with its operational head office located in Lisbon, Portugal and its main base of operations located in Santarem District, Portugal. The Company’s mission is to provide European medical patients with unparalleled cannabis experiences through the production, marketing, distribution and sale of premium quality cannabis products.
-2-
For further information, please contact:
Southern Harvest Health Corp.
Nathan Shantz
416-727-4554
Nshantz@southernharvest.ca